Nasdaq:US$15.15 (-0.54) | HKEX:HK$23.20 (-1.15) | AIM:£2.31 (-0.12)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models